Lantheus Holdings (NASDAQ: LNTH) announced that the U.S. Food and Drug Administration has approved TAUKLARIFY (florquinitau F 18 injection), a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA